ImmunityBio, Inc. (IBRX)
10.28
+1.00
(+10.83%)
USD |
NASDAQ |
Oct 02, 16:00
10.30
+0.02
(+0.15%)
After-Hours: 20:00
ImmunityBio Profit Margin (Quarterly) : -449.6% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -449.6% |
| March 31, 2026 | -1.43K% |
| December 31, 2025 | -161.8% |
| September 30, 2025 | -209.8% |
| June 30, 2025 | -350.3% |
| March 31, 2025 | -785.0% |
| December 31, 2024 | -783.6% |
| September 30, 2024 | -1.40K% |
| June 30, 2024 | -12.85K% |
| March 31, 2024 | -335.3K% |
| December 31, 2023 | -167.9K% |
| September 30, 2023 | -116.6K% |
| June 30, 2023 | -337.1K% |
| March 31, 2023 | -32.38K% |
| December 31, 2022 | -148.4K% |
| September 30, 2022 | -94.20K% |
| June 30, 2022 | -271.0K% |
| March 31, 2022 | -735.7K% |
| December 31, 2021 | -23.48K% |
| September 30, 2021 | -134.0K% |
| June 30, 2021 | -26.37K% |
| March 31, 2021 | -57.90K% |
| December 31, 2020 | -153.0K% |
| September 30, 2020 | -32.02K% |
| Date | Value |
|---|---|
| June 30, 2020 | -2.01M% |
| March 31, 2020 | -87.54K% |
| December 31, 2019 | -173.8K% |
| September 30, 2019 | -129.8K% |
| June 30, 2019 | -98.13K% |
| March 31, 2019 | -357.7K% |
| December 31, 2018 | -247.7K% |
| September 30, 2018 | -76.24K% |
| June 30, 2018 | -693.3K% |
| March 31, 2018 | -550.4K% |
| December 31, 2017 | -204.1K% |
| September 30, 2017 | -299.6K% |
| June 30, 2017 | -167.5K% |
| March 31, 2017 | -222.9K% |
| December 31, 2016 | -173.1K% |
| September 30, 2016 | -265.8K% |
| June 30, 2016 | -283.3K% |
| March 31, 2016 | -511.3K% |
| December 31, 2015 | -548.7K% |
| September 30, 2015 | -426.5K% |
| June 30, 2015 | -92.95K% |
| March 31, 2015 | -3.86K% |
| December 31, 2014 | -2.79K% |
| March 31, 2014 | -404.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -539.3% |
| Sarepta Therapeutics, Inc. | -1.22% |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -183.9% |
| Return on Invested Capital | -356.0% |
| Gross Profit Margin (Quarterly) | 90.82% |
| Operating Margin (Quarterly) | -120.4% |
| Return on Net Operating Assets | -431.9% |